To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
9 Current news of Rudolf-Virchow-Zentrum/ DFG-Forschungszentrum für Experimentelle Biomedizin der Universität Würzburgrss
|You can refine your search further. Select from the filter options on the left to narrow down your results.|
Understand bacterial defense mechanisms in detail
In stress situations, bacteria use special ion channels for defense. Understanding how they function provides the basis for combating harmful bacteria. A Würzburg research group in cooperation with ETH Zurich and the University of Oxford has now been able to decipher how two of these channels are ...
New findings provide a structural framework for the development of new cancer-therapeutic strategies
Collaborative work of research groups at the University of Würzburg and the TU Dresden has provided important new insights for cancer research. During cell division specific target proteins have to be turned over in a precisely regulated manner. To this end specialized enzymes label the target ...
Exact functionality of the protein complex CDK-activating kinase (CAK) resolved
A research group from Würzburg has now been able to clarify the long-standing question of how the protein complex CDK-activating kinase (CAK), which controls the central processes of cell division and transcription, is activated. The group analyzed the active form of the protein/CAK complex and ...
Starting point for drug development against thrombosis, heart attack and stroke
The previously largely unknown molecule bridging integrator 2 (BIN2) plays a central role in platelet activation, as researchers from Würzburg have now shown in a joint project of the DFG Collaborative Research Centre/Transregio 240. This finding provides indications of starting points for drug ...
Research group prints the first biologically correct 3D model of the SARS-CoV-2 virus
Viruses are tiny. They cannot be seen with the naked eye and they are even too small for optical microscopes, which makes it difficult to recognize the danger that COVID-19 and its pathogen SARS-CoV-2 pose to the world. This is why the international Coronavirus Structural Task Force led by Dr. ...
Scientists at the University Würzburg and University Hospital of Würzburg found that megakaryocytes act as “bouncers” and thus modulate bone marrow niche properties and cell migration dynamics. Hematopoiesis is the process of forming blood cells, which occurs predominantly in the bone marrow. The ...
A new guide for cancer drugs
Researchers from the Rudolf Virchow Center of the University of Würzburg (JMU) have solved the structures of the cancer-promoting enzymes USP25 and USP28 and identified significant differences in their activities. Both enzymes promote the growth of various tumors. The results were published in ...
How animal cells protect themselves against dangerous goods
In two recent papers, scientists Ahmad Fazeli and Ann Wehman from the University of Würzburg have published new insights into waste disposal in animal cells. These findings may help to better understand the molecular mechanisms underlying autoimmune diseases like lupus. Animal cells have ...
International scientists led by Carsten Hoffmann and Martin Lohse of the University Würzburg, Germany, identified for the first timeβ-Arrestin as an independent signaling molecule. The protein modulates a pharmaceutically important pathway. It leads to new drug targets, for example in pain ...